Analyst Price Target is GBX 1,724
▲ +30.41% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for CVS Group in the last 3 months. The average price target is GBX 1,724, with a high forecast of GBX 2,000 and a low forecast of GBX 1,420. The average price target represents a 30.41% upside from the last price of GBX 1,322.
Current Consensus is
Moderate Buy
The current consensus among 5 polled investment analysts is to moderate buy stock in CVS Group. This rating has held steady since October 2025, when it changed from a Buy consensus rating.
CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
Read More